|
1）Sancho D, Gómez M, Sánchez-Madrid F. CD69 is an immunoregulatory molecule induced following activation. Trends Immunol. 2005; 26: 136-40
|
|
|
|
2）Ziegler SF, Ramsdell F, Hjerrild KA, et al. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol. 1993; 23: 1643-8
|
|
|
|
|
|
3）Marzio R, Mauël J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol. 1999; 21: 565-82
|
|
|
|
|
|
4）Murata K, Inami M, Hasegawa A, et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol. 2003; 15: 987-92
|
|
|
|
|
|
5）Miki-Hosokawa T, Hasegawa A, Iwamura C, et al. CD69 controls the pathogenesis of allergic airway inflammation. J Immunol. 2009; 183: 8203-15
|
|
|
|
|
|
6）Yamauchi K, Kasuya Y, Kuroda F, et al. Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir Res. 2011; 12: 131-41
|
|
|
|
|
|
7）Tsuyusaki J, Kuroda F, Kasuya Y, et al. Cigarette smoke-induced pulmonary inflammation is attenuated in CD69-deficient mice. J Recept Signal Transduct Res. 2011; 31: 434-9
|
|
|
|
|
|
8）Ishizaki S, Kasuya Y, Kuroda F, et al. Role of CD69 in acute lung injury. Life Sci. 2012; 90: 657-65
|
|
|
|
|
|
9）喘息予防・管理ガイドライン2012作成委員, 日本アレルギー学会 喘息ガイドライン専門部会. 喘息予防・管理ガイドライン2012. 東京：協和企画；2012
|
|
|
|
|
|
10）Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med. 1990; 323: 1033-9
|
|
|
|
|
|
11）Fukutomi Y, Nakamura H, Kobayashi F, et al. Nationwide cross-sectional population-based study on the prevalences of asthma and asthma symptoms among Japanese adults. Int Arch Allergy Immunol. 2010; 153: 280-7
|
|
|
|
|
|
12）Raghu G, Collard HR, Egan JJ, et al, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183: 788-824
|
|
|
|
|
|
13）日本呼吸器学会COPDガイドライン第4版作成委員会. COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン第4版. 東京：メディカルビュー社；2013
|
|
|
|
|
|
14）Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994; 149: 818-24
|
|
|
|
|